Evome Medical Technologies Inc.
LNDZF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $16,183 | $11,439 |
| - Cash | $1,413 | $1,074 | $232 | $919 |
| + Debt | $17,465 | $19,385 | $21,921 | $24,690 |
| Enterprise Value | $16,052 | $18,311 | $37,872 | $35,210 |
| Revenue | $10,011 | $10,539 | $12,071 | $15,722 |
| % Growth | -5% | -12.7% | -23.2% | – |
| Gross Profit | $3,562 | $3,317 | $3,926 | $5,537 |
| % Margin | 35.6% | 31.5% | 32.5% | 35.2% |
| EBITDA | $1,157 | -$1,375 | -$2,604 | -$13,286 |
| % Margin | 11.6% | -13% | -21.6% | -84.5% |
| Net Income | -$1,149 | -$2,284 | -$4,286 | -$15,813 |
| % Margin | -11.5% | -21.7% | -35.5% | -100.6% |
| EPS Diluted | 0 | 0 | 0 | -0.209 |
| % Growth | – | – | 100% | – |
| Operating Cash Flow | $1,786 | $3,123 | -$612 | $1,108 |
| Capital Expenditures | -$22 | $0 | -$38 | $24 |
| Free Cash Flow | $1,764 | $3,123 | -$651 | $1,132 |